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Abstract—Measurement of the mechanical properties of
single cells is of increasing interest both from a fundamental
cell biological perspective and in the context of disease
diagnostics. In this study, we show that tracking cell shape
dynamics during trypsin-induced de-adhesion can serve as a
simple but extremely useful tool for probing the contractility
of adherent cells. When treated with trypsin, both SW13/
epithelial cells and U373 MG glioma cells exhibit a brief lag
period followed by a concerted retraction to a rounded
shape. The time–response of the normalized cell area can be
ﬁt to a sigmoidal curve with two characteristic time constants
that rise and fall when cells are treated with blebbistatin and
nocodazole, respectively. These differences can be attributed
to actomyosin-based cytoskeletal remodeling, as evidenced
by the prominent buildup of stress ﬁbers in nocodazole-
treated SW13/ cells, which are also two-fold stiffer than
untreated cells. Similar results observed in U373 MG cells
highlights the direct association between cell stiffness and the
de-adhesion response. Faster de-adhesion is obtained with
higher trypsin concentration, with nocodazole treatment
further expediting the process and blebbistatin treatment
blunting the response. A simple ﬁnite element model
conﬁrms that faster contraction is achieved with increased
stiffness.
Keywords—Focal adhesion, Stress ﬁber, Cytoskeleton, Myosin,





NMMII non-muscle myosin II
INTRODUCTION
Adhesion of cells to the extracellular matrix (ECM)
is key to many aspects of cell physiology including
tissue assembly and homeostasis, motility, prolifera-
tion, death, and diﬀerentiation. The dynamic equilibrium
between a cell and its ECM is established through the
balance between the contractile forces exerted by
the cell and the resistance to deformation oﬀered by
the ECM (i.e., ECM rigidity). The cell’s ability to sense
mechanical cues from the ECM is made possible by
engagement and clustering of integrins and formation
of focal adhesions, which physically anchor the ECM
to the actin cytoskeleton.33 Cell mechanobiology
involves the study of the mechanisms by which cells
sense and respond to mechanical forces, as well as
characterization of the mechanical properties of the
cell. Cell stiffness or elasticity has emerged as a useful
metric for characterizing the mechanical properties of
a cell, particularly given that alterations in cell stiffness
and/or ECM stiffness often reﬂect or drive disease
progression, as observed in the reduced deformability
of malaria-infected red blood cells,23 increased stiffness
of leukemic cells34 and breast tumor tissue,28 and
enhanced migration and proliferation of glioma cells.46
Increases in actomyosin contractility concomitantly
increase cell stiffness49 and enable cells to stress and
remodel the ECM.
The fundamental importance of cell mechanobiol-
ogy and its increasingly appreciated role in physiology
and disease have fueled tremendous interest in
developing methods for measuring the mechanical
properties of both single cells and populations of cells.
Single-cell micromanipulation techniques include micro-
pipet aspiration (MA),6,11,15 atomic force microscopy
(AFM),34,36,40 magnetic bead twisting cytometry
(MTC),12,30,47 and optical tweezers (OT),1,14,26 and
typically involve the application of normal or tangen-
tial forces in the piconewton (pN) to nanonewton (nN)
range. These methods can be utilized for probing
individual cells and measuring the elastic or visco-
elastic properties of the cell membrane and various
subcellular components. In contrast to these single-cell
approaches, centrifugation and hydrodynamic assays
are used for probing large cell populations and involve
the application of either centrifugal forces or shear
forces to measure adhesion strength.4,21 Recent
advances in microfabrication permit the application of
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forces to single or multiple cells with enhanced control
of forces and displacements and at signiﬁcantly higher
throughput. For instance, a microﬂuidic device was
recently designed for assessing the deformability of
blood cell populations by measuring their transit times
through a network of capillaries mimicking blood
vessels.35 The type of biophysical assay used to probe a
particular cell is dictated by its stiffness and the bio-
logical process being studied. Although single-cell
micromanipulation techniques provide precise mea-
surements of cell mechanical properties, they are low-
throughput and limited by both their high equipment
cost and time- and skill intensity. This underscores the
need for developing additional simple techniques that
do not involve any expensive equipment, are high-
throughput, and can measure changes in cell mechani-
cal properties associated with disease or speciﬁc
physiologic perturbations.
Recent studies have raised the intriguing possibility
that the adhesive and de-adhesive dynamics between
cells and the ECM may be used to interrogate cellular
mechanics. For example, Wildt et al. used a chip-based
device composed of RGD-functionalized arrays of
microscale gold strips on a glass substrate to study the
detachment dynamics of 3T3 ﬁbroblasts at the sub-
cellular level.50 Rapid release of RGD peptides effected
by applying a low voltage pulse across the gold strips
led to a corresponding detachment response by the cell
characterized by a delay (termed induction time) fol-
lowed by cell contraction. Both the induction time and
the contraction time were shown to depend on cell
contractility, with blebbistatin treatment resulting in a
progressive increase in both the time scales in a
concentration-dependent manner. Similar contractility-
dependent retraction dynamics had been reported ear-
lier in the ATP-dependent or trypsin-dependent
rounding of endothelial cells,41 shape changes in endo-
thelial cells after microneedle-induced cell detach-
ment,29 and the relaxation of intact myotubes after
mechanical detachment of one end by a glass micropi-
pet.13 In all of these studies, the delayed morphological
response of cells when treated with actin-disrupting or
myosin-inhibiting drugs highlights the role of actomy-
osin contractility in stressing the ECM and contributing
to intracellular tension.
Motivated by the need for high-throughput meth-
ods for studying single-cell mechanics and the hint
from previous studies of a potential connection
between de-adhesion and cellular contractility, we
developed a simple and rapid assay to infer cellular
mechanical properties from cellular de-adhesive dynam-
ics following protease-mediated detachment from the
ECM. Upon treatment with trypsin, both SW13/
epithelial cells and U373 MG glioma cells exhibited a
brief lag period followed by a concerted retraction to a
rounded shape. The time–response of the normalized
cell area could be ﬁt to a sigmoidal curve with two
characteristic time constants whose values were sensi-
tive to contractile agonists. By tracking cytoskeletal
organization and measuring cortical elasticity by AFM
nanoindentation, we correlated changes in retraction
kinetics to actomyosin-based remodeling. Further sup-
port for the connection between de-adhesive dynamics
and cellular mechanics was provided by ﬁnite-element
simulations, which revealed acceleration of detachment
kinetics as cellular elasticity was increased or viscous
drag was decreased. Taken together, our results indicate
an inverse relationship between the de-adhesion time
constants and cell stiffness, and establish the utility of
using trypsin-induced de-adhesion as an effective tool
for probing cell contractility.
MATERIALS AND METHODS
Cell Culture
SW13/ cells were cultured at 37 C in a humidi-
ﬁed atmosphere of 95% air and 5% CO2 in DMEM
(Invitrogen) supplemented with 5% fetal calf serum
(J R Scientiﬁc, CA). U373 MG human glioblastoma
cells (American Type Culture Collection, MD) were
cultured under identical conditions in DMEM sup-
plemented with 10% fetal calf serum, 1% sodium
pyruvate (Invitrogen), 1% non-essential amino acids
(Invitrogen), and 1% penicillin/streptomycin (Invitro-
gen). Cells were maintained in 75 cm2 cell culture
ﬂasks (Corning, NY), harvested with 0.25% trypsin-
EDTA (Invitrogen), and passaged every 2–3 days. For
experiments, cells were plated on glass coverslips
coated with 0.05 mg/mL bovine collagen I (Inamed
Biosciences). For de-adhesion studies, cells were incu-
bated with nocodazole or blebbistatin (both from
Sigma) or Cytochalasin D (Calbiochem) at the speci-
ﬁed concentration for 1 h before trypsinization (see
below).
Immunoﬂuorescence Labeling and Antibodies
Cultured cells were rinsed twice with phosphate-
buﬀered saline (PBS) (Fisher Scientiﬁc), ﬁxed with 4%
para-formaldehyde solution for 10 min, permeabilized
with 0.5% Triton X-100, and blocked in 5% BSA for
1 h at room temperature. Cells were incubated for 1 h
at room temperature in one of the following primary
antibody solutions in PBS at the speciﬁed dilutions:
mouse anti-vinculin (1:200, Sigma), mouse anti-
NMMII (1:200, Santa Cruz). After incubation with
primary antibody, cells were rinsed twice with PBS and
then incubated with Alexa 543 goat anti-mouse IgG
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(1:500, Invitrogen), and Alexa 488-phalloidin (1:200,
Invitrogen) for 1 h at room temperature. Cell nuclei
were labeled with DAPI (1:500, Invitrogen). Samples
were mounted onto slides using Cytoseal 60 (Richard-
Allan Scientiﬁc).
Image Acquisition and Analysis
Both live cell and epiﬂuorescence imaging were
performed using a Nikon TE2000E2 microscope
equipped with an incubator chamber for controlled
temperature, humidity, and CO2. Images were
recorded with a CCD camera (Photometrics Cool-
SNAP HQ2) interfaced to image acquisition software
(Compix SimplePCI). For de-adhesion experiments,
media was removed, and cells were brieﬂy washed with
PBS and then incubated with warm trypsin (either
2.5 g/L trypsin with 0.38 g/L EDTA (low activity) or
5 g/L trypsin with 2 g/L EDTA (high activity)). Cells
were imaged every 5 or 10 s at 920 magniﬁcation until
cells became rounded with no further apparent change
in spread area, and after some delay, eventually
detached. The dynamics of de-adhesion were tracked
only for the time span when cells were still attached to
the substrate. Further, while imaging, the focal plane
was set at the cell–substrate interface at the start of the
de-adhesion process to ensure that the contact area
was being monitored. To quantify de-adhesion, cell–
substrate contact area (subsequently referred to as
‘‘cell area’’) was determined by tracing the outline of
the cell at different time points using ImageJ (NIH).
The time-dependent normalized area was quantiﬁed by
dividing the difference between the cell area at time t
and the initial spread area (i.e., Ainitial  A(t)) by the
difference in area between the ﬁrst and last time points
(i.e., Ainitial  Aﬁnal). Thus, the plot of normalized area
increases from a value of 0 (at t = 0, A(t) = Ainitial) to
a value of 1 (at t = tﬁnal, A(t) = Aﬁnal). The normal-
ized area-vs.-time data were then ﬁt to a sigmoidal
curve to yield the time constants.
Atomic Force Microscopy
Cells were cultured on glass coverslips as described
above. Samples were mounted onto the stage of an
AsylumMFP3DAFM (AsylumResearch, CA) coupled
to a Nikon TE2000E2 epiﬂuorescence microscope and
indented using a pyramid-tipped probe (Veeco Instru-
ments) with nominal spring constant of 60 pN/nm.
Actual spring constants were determined using the
thermal calibrationmethod. Force curves were obtained
for 40–50 cells for each condition. Each proﬁle was ﬁt
with a modiﬁed Hertzian model of a cone indenting a
semi-inﬁnite elastic material to extract a set of elastic
moduli.36
Computational Model of De-Adhesion
An axisymmetric ﬁnite element model was devel-
oped to simulate de-adhesion dynamics. In this model,
cells were compelled to transition from an initially
stretched or spread state (S) to a ﬁnal rounded or
relaxed state (R). The cell was modeled as a homoge-
neous, isotropic, elastic solid with a prescribed
Young’s modulus (Ecell), and as undergoing Rayleigh
damping with a stiffness damping parameter (b).
Because perfectly incompressible materials have a
Poisson’s ratio of 0.5, and cells are slightly compress-
ible, we ﬁxed the Poisson ratio of the cell at 0.45 for all
simulations, which falls well within the range of values
used in literature for analysis of AFM indentation
measurements.31,39 We also performed parameter sen-
sitivity studies, which revealed negligible differences in
the simulated curves for Poisson’s ratio values between
0.4 and 0.5. The ‘stress-free’ rounded state of the cell
was modeled as a disk 20 lm in height and 20 lm in
radius. A zero radial displacement boundary condition
was imposed on the centerline to ensure symmetry. To
isolate effects of contractility, we assumed a frictionless
interface between the bottom edge of the cell and the
underlying substrate, and that all adhesions were dis-
rupted simultaneously and instantaneously upon
addition of trypsin. Therefore, the bottom edge is
constrained in z-direction but is free to slide in a fric-
tionless manner in the radial direction. The initial state
of de-adhesion (i.e., the spread shape) was generated
by imposing a prescribed displacement (or stretch) on
the outer edge, and solving the static problem, with the
stretched state serving as the input for the subsequent
de-adhesion simulations. The de-adhesion process was
then simulated by imposing free boundary conditions
on the outer edge and solving the transient problem.
To quantify de-adhesion dynamics, we applied the area
normalization scheme outlined above, with the base
radius r(t) at any time step converted to an area
measured by assuming a circular contact interface. To
simulate the effect of contractility and viscosity, we
varied the Young’s modulus and Rayleigh damping
parameter, respectively.
RESULTS
De-Adhesion Dynamics of SW13/ Cells
To quantify cellular de-adhesion dynamics, we
developed an assay in which we severed cell–matrix
adhesive contacts with trypsin and followed the cellu-
lar retraction that precedes cell detachment (Fig. 1a).
Our initial studies focused on SW13/ cells, an epi-
thelial line that lacks cytoplasmic intermediate ﬁla-
ments38 and therefore serves as an excellent model
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system for studying the relative contributions of the
actin and microtubule cytoskeletons to cell structure
and mechanics. Upon treatment with trypsin, control
cells retracted and rounded within 100–150 s, whereas
cells treated with the microtubule poison nocodazole
retracted and rounded within 50–100 s (Fig. 1b). To
quantify retraction kinetics, we tracked the average
normalized cell–substrate contact area (see Methods)
as a function of time (Fig. 1c). In both cases, the
detachment response of these cells was sigmoidal and
composed of three well-deﬁned phases: an initial delay,
a rapid cell contraction, and a plateau or saturation.
This quantiﬁcation conﬁrmed our qualitative obser-
vations, i.e., whereas control cells took 150 s to reach
>95% saturation, nocodazole-treated cells detached
much more quickly and achieved this same level of
saturation within 100 s. To further quantify this
retraction, we ﬁt each of these curves to a Boltzmann
sigmoid equation, which yielded two characteristic
time constants, s1 and s2 (Fig. 1d). Whereas s1 ~ 90 s
for control cells, s1 ~ 50 s for nocodazole-treated cells,
which represents a statistically signiﬁcant difference of
45%. Similarly, nocodazole treatment led to a 40%
reduction in s2 (~15 s and ~9 s for control and
nocodazole-treated and cells, respectively). When cells
were treated with the actin-disrupting drug cytochala-
sin D, cells rapidly collapsed even prior to trypsin
treatment (see below) and the de-adhesion process was
FIGURE 1. De-adhesion dynamics of SW132/2 cells. (a) Schematic of trypsin de-adhesion assay. At time t = 0, media was
removed, and cells were briefly washed with PBS and then incubated with warm trypsin. Cells were imaged every 5 or 10 s at low
magnification (320) until cells became rounded. (b) De-adhesion dynamics of untreated (CTL) and 10 lM nocodazole-treated
(Nocod.) SW132/2 cells. Scale bar = 90 lm. (c) Quantification of cell shape changes during de-adhesion. Cell de-adhesion was
quantified by plotting the normalized area as a function of time. The detachment response of both control and drug-treated cells
was sigmoidal with nocodazole treatment causing faster de-adhesion as observed in the left shift of the sigmoidal curve. (d) Effect
of cytoskeletal inhibitors on time constants of retraction. The normalized area-vs.-time data were fit to a Boltzmann sigmoid
equation to determine the time constants s1 and s2. Faster de-adhesion with nocodazole treatment yielded smaller values for both
the time constants (*p< 0.01).
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signiﬁcantly delayed or completely abolished, render-
ing the retraction data unable to yield time constants
(data not shown).
Retraction Dynamics Correlate with Cytoskeletal
Architecture and Cell Mechanics in SW13/ Cells
The faster de-adhesion dynamics observed with
nocodazole treatment and the ability of cytochalasin D
to disrupt this response suggest that these dynamics
depend on the structure and mechanics of the actin and
microtubule cytoskeletons. To explore this possibility,
we visualized the actin and microtubule networks of
SW13/ cells in the presence and absence of noco-
dazole and cytochalasin D. Control cells exhibited
thick cortical actin bundles at cell margins and cell–
cell boundaries but essentially were devoid of well-
developed stress ﬁbers (Fig. 2a). Disruption of the
microtubule network with nocodazole led to a signiﬁ-
cant reorganization of the actin network, with the
emergence of stress ﬁbers spanning the entire length of
the cell, consistent with previous observations that
nocodazole increases cellular tractional forces.16 In
contrast, cytochalasin D treatment caused cells to
collapse into stellate structures with extended, tubulin-
positive membrane protrusions.
The ﬁnding that these drug treatments altered both
de-adhesion dynamics and cytoskeletal architecture led
us to reason that these observations resulted from a
common underlying mechanism: altered cellular
mechanics. To test this hypothesis directly, we used
AFM nanoindentation to measure the elastic moduli
of SW13/ cells in the setting of cytoskeletal inhibi-
tion. While control cells were found to have a mean
elasticity of 1.6 kPa, nocodazole-treated cells were
nearly 2-fold stiffer at a mean stiffness of 3 kPa, con-
sistent with the observation that cells develop stress
ﬁbers under these conditions. By contrast, cytochalasin
D-treated cells were signiﬁcantly softer at 0.8 kPa,
representing a 50% decrease in elasticity compared to
control cells. Taken together, these results strongly
suggest that the changes in the de-adhesion time con-
stants obtained with nocodazole and cytochalasin D
treatment can be explained by an increase in cell
stiffness in the treated cells. More speciﬁcally,
de-adhesion dynamics are inversely correlated with cell
stiffness.
De-Adhesion Dynamics of U373 MG Glioma Cells
While the above observations with SW13/ cells
suggest that cell stiffness is a critical regulator of
de-adhesion dynamics, the interpretation of these re-
sults is complicated by the fact that SW13/ cells
grow in clusters, which may introduce contributions of
cell–cell adhesion and mechanics. To directly evaluate
the role of contractility in cells a culture system that
lacks these contributions, we repeated the de-adhesion
FIGURE 2. Effect of cytoskeletal inhibition on cytoarchitec-
ture and cortical mechanics of SW132/2 cells. (a) Cytoarchi-
tecture. SW132/2 cells were treated with either microtubule
disrupting drug nocodazole (10 lM) or actin disrupting drug
cytochalasin D (0.5 lM) for 1 h. Subsequent phalloidin stain-
ing of F-actin and immunofluorescence against b-tubulin
revealed the redistribution of these two proteins. In contrast
to control cells which exhibit thick cortical actin bundles at
cell margins and cell–cell boundaries but no stress fibers,
nocodazole treatment led to emergence of stress fibers
spanning the entire length of the cell. In comparison, cyto-
chalasin D treatment caused cells to collapse into stellate
structures with extended, tubulin-positive membrane protru-
sions. Scale bar = 15 lm. (b) Cortical cell stiffness. Cortical
cell stiffness of control and drug-treated cells was measured
with AFM nanoindentation. Compared to controls, drug
treatment causes significant differences in cell stiffness
(*p< 0.01), with nocodazole treatment causing cell stiffening,
and cytochalasin D treatment causing cell softening.
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experiments with U373 MG glioma cells. U373 MG
cells differ from SW13/ cells in two important
respects: First, when cultured sparsely, U373 MG cells
tend to form neither multicellular clusters nor well-
developed cell–cell adhesive contacts (Fig. 3a). Second,
whereas SW13/ cells adopt a relatively non-polar
morphology on collagen coated glass (Fig. 2), U373
MG cells elongate and spread extensively (Fig. 3a).
When exposed to trypsin, U373 MG cells began to
retract and round within 20 s and achieved a com-
pletely rounded morphology within 60 s (Fig. 3b). As
with the SW13/ cells, these de-adhesion dynamics
followed sigmoidal proﬁles, which yielded character-
istic time constants of s1 ~ 26 s and s2 ~ 8 s (Fig. 3c).
Compared to SW13/ cells, this represents a ~67%
reduction in s1 and a ~50% reduction in s2, illustrating
that the speciﬁc details of the retraction dynamics are
cell-type speciﬁc. However, like the SW13/ cells,
nocodazole treatment led to faster de-adhesion with
time constants of s1 ~ 13 s and s2 ~ 5 s (Fig. 3c). When
we attempted to repeat the cytochalasin D studies
(Figs. 1 and 2) with U373 MG cells, we observed that
these cells rounded rapidly, did not retract further upon
trypsinization, and frequently spontaneously detached,
making it challenging for us to either extract time
constants or acquire reliable immunostains. Thus, we
chose instead to treat these cells with blebbistatin, a
non-muscle myosin II (NMMII) inhibitor that dissi-
pates contractility without disassembling the actin
cytoskeleton. Under these conditions, we found that
cell de-adhesion was signiﬁcantly delayed, with time
constants of s1 ~ 45 s and s2 ~ 12 s (Fig. 3c). Taken
together, these results clearly indicate that the
de-adhesion dynamics of glioma cells correlate strongly
and quantitatively with the mechanical state of the cell.
Retraction Dynamics Correlate with Cytoskeletal
Architecture and Cell Mechanics in U373 MG Cells
Our earlier results with SW13/ cells (Figs. 1 and
2) demonstrate that faster de-adhesion correlates with
both development of cytoskeletal structures associated
with increased cortical stiffness. To gain additional
mechanistic insight into these changes, we immuno-
stained drug-treated U373 MG cells for vinculin, a
marker of mature focal adhesions, and NMMII, the
molecular motor whose activity underlies stress ﬁber
contractility (Fig. 4a). Unlike SW13/ cells, U373
MG cells formed a prominent stress ﬁber network at
baseline and did not develop this network further when
treated with nocodazole. However, vinculin staining at
focal adhesions was more intense and polarized in
nocodazole-treated cells compared to controls. More-
over, NMMII, which is diffusely distributed through-
out the cytoplasm in control cells, localized very
strongly along stress ﬁbers and the cortical actin net-
work (arrowheads), which reﬂects a more contrac-
tile actin cytoskeleton. Treatment with blebbistatin
FIGURE 3. De-adhesion dynamics of U373 MG glioma cells.
(a) De-adhesion dynamics of individual U373 MG glioma cells.
Scale bar = 75 lm. (b) Quantification of cell shape changes
during de-adhesion. Plot of normalized cell area for control,
5 lM nocodazole-treated (Nocod.), and 5 lM blebbistatin-
treated (Blebb.) U373 MG cells. While nocodazole treatment
caused faster de-adhesion, blebbistatin treatment led to
slower de-adhesion. (c) Effect of cytoskeletal inhibitors on
time constants of retraction. Differences in s1 and s2 were
statistically significant for both nocodazole treatment
(*p< 0.1) and blebbistatin treatment (*p< 0.001).
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completely disassembled the stress ﬁber network and
induced membrane rufﬂing. While vinculin staining
was diffusely distributed throughout the cytoplasm,
the membrane rufﬂes stained strongly for NMMII
(arrowheads). AFM measurements conﬁrmed that
these drug-induced cytoskeletal alterations were
indeed correlated with a more contractile state for the
nocodazole-treated cells and a relaxed state for
blebbistatin-treated cells. Compared to a mean stiffness
of ~4.5 kPa for control cells, nocodazole-treated cells
were ~55% stiffer at ~7 kPa (Fig. 4b). Blebbistatin
treatment signiﬁcantly softened cells and yielded a mean
stiffness of 2.8 kPa. Taken together, our de-adhesion,
immunostaining and AFM results establish a clear con-
nection between cell stiffness and de-adhesion dynamics.
Eﬀect of Trypsin Activity on De-Adhesion
Our results above establish that changes in
de-adhesion dynamics correlate strongly with the
development or dissipation of contractile cytoskeletal
elements and with cortical stiﬀness, and that these
trends are qualitatively independent of cell–cell con-
tacts. However, it occurred to us that our observed
de-adhesion dynamics might also depend on the rate of
disruption of cell–substrate adhesions (i.e., trypsin/
EDTA activity), which might vary across drug treat-
ments and cell lines. To directly determine the inﬂuence
of focal adhesion disassembly on de-adhesion, we
repeated our de-adhesion experiments in the presence
of cytoskeletal drugs with two diﬀerent trypsin/EDTA
concentrations: 2.5 g/L trypsin with 0.38 g/L EDTA
(‘‘low-activity’’), and 5 g/L with 2 g/L EDTA (‘‘high-
activity’’) (Fig. 5). As expected, for untreated cells, use
of the high-activity formulation produced almost
instantaneous disruption of focal adhesions relative to
the low-activity formulation, with a ~60% reduction in
both of the time constants (Fig. 5a). In nocodazole-
treated cells, compared to low-activity trypsin,
de-adhesion for high-activity trypsin was further accel-
erated and led to a ~40% reduction in s1 (from 12.66 to
7.6 s) and a ~60% reduction in s2 (from 5.13 to 2.2 s)
(Fig. 5b). Interestingly, while high-activity trypsin
caused a ~40% reduction in s1 in blebbistatin-treated
cells relative to 19 trypsin, s2 remained unchanged
(Fig. 5c). This lack of change could be attributed to the
elimination of NMMII-based contractility obtained
with blebbistatin treatment, which would indicate that
s2 depends directly on contractility. In contrast, the
reduction in s1 for all the cases indicates that s1 is
modulated by a complex interplay between focal adhe-
sion disassembly and cell contractility.
Another important diﬀerence between the de-adhesion
curves for low- and high-activity trypsin is that com-
pared to the sigmoidal shape of curves observed with
low-activity trypsin, the de-adhesion curves with
high-activity trypsin were hyperbolic (saturating) in
nature (Fig. 5d). Indeed, these data could be ﬁt with a
single exponential representative of viscoelastic relax-
ation, with t0 representing the initial lag and s the
FIGURE 4. Effect of nocodazole and blebbistatin on cytoar-
chitecture and cortical stiffness in U373 MG cells. (a) Cyto-
skeletal architecture, focal adhesions, and NMMII localization.
U373 MG cells were treated with 5 lM nocodazole or 5 lM
blebbistatin for 1 h and immunostained for vinculin and
NMMII, respectively. Vinculin staining at focal adhesions was
more intense and polarized in nocodazole-treated cells com-
pared to controls, but diffuse in blebbistatin-treated cells.
NMMII was diffusely distributed in control cells, but localized
strongly along stress fibers and cortical actin in nocodazole-
treated cells, and was present at membrane ruffles induced by
blebbistatin treatment. Scale bar = 15 lm. (b) Cortical stiff-
ness. Cortical stiffness alterations in drug-treated U373 MG
cells. Compared to control cells with a mean stiffness of
~4.5 kPa, nocodazole-treated cells were significantly stiffer at
~7 kPa (*p< 0.01), and blebbistatin-treated cells were softer at
~2.8 kPa (**p< 0.001).
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characteristic time constant of relaxation. Irrespective
of drug treatment, the initial de-adhesion response of
both control and drug-treated cells was quite uniform
with an initial lag of 4–5 s. The time constant s
depended on the type of drug treatment with mean
values of ~7 s for control cells, ~4 s for nocodazole-
treated cells, and ~22 s for blebbistatin-treated cells. A
value of t0 ~ 5 s obtained from these ﬁts suggest that t0
is the time required for trypsin to diffuse underneath
the cells and disassemble adhesions. Compared to
controls, a ~40% decrease in s for nocodazole-treated
cells and a ~200% increase in s for blebbistatin-treated
cells highlights the role of actomyosin contractility in
directly modulating de-adhesion.
Finite Element Modeling of De-Adhesion: Cell Stiﬀness
Directly Modulates De-Adhesion
The trypsin concentration-dependence data enable
us to decouple the eﬀects of contractility and focal
adhesion disassembly on de-adhesion dynamics, and
highlight the strong inﬂuence of contractility in mod-
ulating de-adhesion. To further conﬁrm the role of
contractility and cytoplasmic viscosity, we simulated
de-adhesion in a ﬁnite element model in which we
could independently vary the elastic modulus of the
cell (Ecell) and the internal damping coefﬁcient (b). It is
important to note that our model only recapitulates
the last phase of de-adhesion dynamics after all adhe-
sions have disassembled. Similar to damped oscillation
of a spring-dashpot system, the transient relaxation of
our model cell depended directly on b. While high
values of b delayed relaxation, as would be expected
for an over-damped system, smaller values of b led to
under-damping, with critical damping obtained in the
range of b ~ 1 9 105–5 9 105. For a cell with pre-
scribed stiffness and b, different values of imposed
initial stretch lead to the same normalized de-adhesion
proﬁle (data not shown). We assessed the relationship
between cell stiffness and de-adhesion dynamics by
FIGURE 5. Effect of trypsin activity on de-adhesion dynamics of U373 MG cells. (a) De-adhesion dynamics of untreated U373 MG
cells exposed to low-activity trypsin and high-activity trypsin, respectively (see Methods). Compared to low-activity trypsin,
de-adhesion at high-activity trypsin was faster with a ~60% reduction in both of the time constants. (b) De-adhesion dynamics of
nocodazole-treated U373 MG cells at low- and high-activity trypsin. In nocodazole-treated cells, compared to low-activity trypsin,
de-adhesion with high-activity trypsin led to a ~40% reduction in s1 and a ~60% reduction in s2. (c) De-adhesion dynamics of
blebbistatin-treated U373 MG cells at low- and high-activity trypsin. Though high-activity trypsin caused a ~40% reduction in s1 in
blebbistatin-treated cells relative to low-activity trypsin, s2 remained unchanged. (d) De-adhesion dynamics of untreated and drug-
treated cells at high-activity trypsin fitted with a single exponential representative of viscoelastic relaxation. Compared to controls,
the time constant of relaxation (s) was lower for nocodazole-treated cells and higher for blebbistatin-treated cells.
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ﬁxing the damping parameter (2 9 105) and varying
the cell stiffness over 3 orders of magnitude from 0.1 to
10 kPa (Fig. 6b). At 0.1 kPa, de-adhesion was found
to be almost linear indicating little or no change in
area. Increasing stiffness led to faster de-adhesion as
observed in the left shift of the curves (2 and 10 kPa,
respectively). The overshoot observed at 2 kPa indi-
cates the system is under-damped for the choice of
stiffness and b. The fastest dynamics observed at
10 kPa establishes the direct inﬂuence of cell stiffness
in modulating de-adhesion.
DISCUSSION
In this study, we have demonstrated that trypsin-
induced de-adhesion can be used as a simple yet
eﬀective tool for probing the contractility of adherent
cells. We found that when treated with trypsin,
adherent cells detach and round with sigmoidal
dynamics. The time constants of this process are sen-
sitive to cytoskeletal inhibitors, with nocodazole and
blebbistatin treatment accelerating and delaying
de-adhesion, respectively. Contractility-dependent
alterations of these time constants closely mirror
alterations in the stiﬀness of drug-treated cells, with
nocodazole and blebbistatin treatment signiﬁcantly
enhancing and lowering cell stiﬀness, respectively. The
observation that the de-adhesion dynamics also
depend strongly on the activity of the trypsin formu-
lation highlights the importance of proteolysis and
disassembly of cell–matrix adhesions in regulating the
initial phase of de-adhesion. Finally, we capture the
modulation of de-adhesion by contractility in a simple
ﬁnite element model in which increased cell stiﬀness
leads to faster de-adhesion. Our results thus demon-
strate that de-adhesion time constants scale inversely
with cell contractility and stiﬀness and establish tryp-
sin-induced de-adhesion as a simple tool for probing
the contractility of adherent cells. We anticipate that
this approach may serve as a semiquantitative, high-
throughput complement to single-cell micromechanical
approaches (e.g., AFM, MA, OT), which measure cell
mechanical properties more precisely and directly but
are also both low-throughput and labor- and skill-
intensive. By combining motorized microscopy
platforms and commercially available cell tracking
software, we anticipate that the method can be auto-
mated and made suitable for high-throughput optical
analysis of cell contractility. Furthermore, the sim-
plicity of our technique allows it to be easily integrated
into other high-throughput techniques for cellular
analysis. For example, we envision that cells might be
sorted according to their de-adhesion kinetics and
delivered to a ﬂow cytometry system to correlate
micromechanics to expression of speciﬁc markers.
Given the emerging evidence that altered cellular
mechanics may serve as a biomarker for stem cell
diﬀerentiation10,37 and disease states,23,28,34 such a
system could prove extremely valuable for biopro-
cessing and diagnostic applications.
FIGURE 6. Finite element model of de-adhesion: effect of
cell stiffness. (a) Schematic comparison of cell spreading and
cell de-adhesion. For studying de-adhesion dynamics, an
initial spread shape (S) was generated by stretching the model
disk-shaped cell (R) representative of the final rounded state
observed experimentally. De-adhesion was simulated by
allowing the stretched cell to relax and solving the transient
problem. The simulation parameters include the damping
parameter (b) and the cell stiffness (Ecell). Displacement map
induced by stretching the initially relaxed cell was plotted,
with red being the maximum displacement and blue being
zero displacement. This stretched state served as the starting
cell configuration for solving the transient problem. (b) Sim-
ulated de-adhesion curves obtained for b = 2 3 1025 and Ecell
(kPa) = 0.1, 2.0, and 10.0, respectively.
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For both SW13/ and U373 MG cells, the phar-
macologically induced alterations in cell contractility
led to clear and signiﬁcant changes in the cortical
stiffness of cells by AFM. The close association
between cell prestress (or contractile mechanics) and
stiffness (cortical mechanics) in adherent cells has been
previously demonstrated in human airway smooth
muscle cells44; when cell contractility was modulated
through the use of contractile agonists and antago-
nists, cellular traction forces scaled linearly with cell
stiffness by MTC. This association between contrac-
tility and stiffness has also been observed in the context
of the adaptation of ﬁbroblasts to ECM stiffness.42
Speciﬁcally, ﬁbroblasts match the stiffness of their
underlying ECM substrate for ECM stiffnesses up to
5 kPa and do so without forming stress ﬁbers. At
greater ECM stiffnesses, cell stiffness plateaus and cells
form stress ﬁbers, because they are unable to reinforce
their adhesions further simply by reorganizing the
cortical actin network. Analogous to this, stress ﬁbers
are observed in SW13/ cells only when contractility
is enhanced by nocodazole treatment.
The signiﬁcant decrease in the stiﬀness of cytocha-
lasin D-treated SW13/ cells observed here and else-
where25,45 demonstrate the dominance of F-actin in
determining the stiffness of cells. In addition, the sig-
niﬁcant increase in cell stiffness obtained with noco-
dazole treatment is consistent with the tensegrity
model.17,18 Increased traction in response to microtu-
bule disruption has been reported in various studies
and highlight the reciprocal role for actin and micro-
tubules.5,20,43,48 This has also been observed in 3D
cultures in the enhanced retraction of microtubule-
disrupted smooth muscle cells in a quasi-in situ tensile
test.24 Increased myosin phosphorylation19 and high
intracellular calcium27 observed upon microtubule
disruption may directly contribute to the enhanced
stiffness of nocodazole-treated cells observed here.
By examining multiple cell lines (SW13/ and
U373 MG), we were able to demonstrate the generality
of the method while also observing characteristic cell-
speciﬁc differences in retraction dynamics. While
SW13/ cells grow in clusters and are rounded in
shape, U373 MG cells spread extensively, and have a
more strongly developed stress ﬁber network. Conse-
quently, in comparison to a baseline stiffness of
4.5 kPa measured for U373 MG cells, SW13/ cells
are ~60% softer at 1.6 kPa. The emergence of stress
ﬁbers upon nocodazole treatment in SW13/ cells but
not in U373 MG cells further can be attributed to the
lower contractile state of SW13/ cells. Furthermore,
compared to SW13/ cells, a ~67% reduction in s1
and a ~50% reduction in s2 of U373 MG cells reﬂects
the higher baseline contractility of U373 MG cells and
illustrates the cell-type speciﬁc differences in the
retraction dynamics. Even in blebbistatin-treated U373
MG cells, s1 ~ 45 s, which is still ~50% faster than
control SW13/ cells. Moreover, while blebbistatin-
treated U373 MG cells are softer than untreated U373
MG cells, they have a mean stiffness of 2.8 kPa, which
is ~75% stiffer than untreated SW13/ cells. In
addition to highlighting cell-type differences in base-
line contractility, these results demonstrate that both
cell stiffness and de-adhesion reﬂect the contractile
state of the cell. From our experimental data, cell
stiffness and de-adhesion time constants of SW13/
and U373 cells can be combined to obtain approximate
expressions (Ecell  54s0:7751 (R2 = 0.99) and Ecell 
64s1:3362 (R
2 = 0.94), respectively) which explicitly
relate the cell stiffness to the two time constants.
In addition to providing a method to estimate cell
stiffness, these expressions reinforce the inverse cor-
relation between stiffness and de-adhesion time
constants.
The strong dependence of the detachment dynamics
on trypsin/EDTA activity reveals insight into the
contributions of contractility and focal adhesion dis-
assembly to de-adhesion dynamics. These studies sug-
gest that one time constant reﬂects both adhesion
disassembly and contractility, whereas the other time
constant primarily reﬂects contractility, a notion that is
further supported by our simulated de-adhesion
curves. Also, as expected, de-adhesion depends directly
on cytoplasmic viscosity, represented in our simula-
tions by the damping coeﬃcient. While this exceed-
ingly simple model yields valuable mechanistic insight
into de-adhesion dynamics, much room remains for
additional sophistication. For example, our simula-
tions model only the second phase of high-activity
trypsin experiments, i.e., they assume instantaneous
breakage of all adhesions and frictionless sliding of the
cell on the substrate dictated solely by cell stiﬀness.
Incorporation of position- or time-dependent trypsin
activity may more faithfully recreate the experimental
de-adhesion curves. Additionally, the model would
likely beneﬁt from a more realistic representation of
cell geometry and cytoarchitecture, including more
explicit description of cytoskeletal ﬁlaments and
assignation of diﬀerent mechanical properties to the
individual components, and inclusion of friction
between the cell surface and the substrate. More
importantly, the temporal eﬀects of focal adhesion
disassembly and contractility on de-adhesion dynamics
can be decoupled by incorporating discrete adhesions
in our simulations. The NMMII isoform NMMIIA
preferentially aﬀects the stability of focal adhesions,3
suggesting that the interplay between adhesion and
contractility may be better captured by allowing the
discrete adhesions to disassemble in a stress- or strain-
dependent manner.
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In traction force microscopy, cellular traction forces
are determined by measuring the displacements of
matrix-embedded beads after dissipation of matrix
strains achieved by physically detaching the cell from
the substrate.2 Recently, tractional stresses and strains
associated with discrete contractile structures were
measured by using laser ablation to sever a single stress
ﬁber while simultaneously tracking bead displacements
in the underlying substrate.22 In this study, traction
force relaxation followed saturation kinetics with a
plateau achieved within 10 s of ablation. The time scale
of relaxation in this study compares well with the time
scale of detachment observed with U373 MG cells. The
dependence of the de-adhesion time constants on cell
contractility suggests that they are directly related to
traction forces and may potentially have value as a
surrogate for directly monitoring the time-dependent
relaxation of traction forces and matrix strains, which
is a signiﬁcantly more time- and labor-intensive
experiment.
Cell motility requires the coordinated extension of
membrane protrusions, formation of transient adhe-
sions, and myosin-dependent detachment of the cell
rear.33 Therefore, precise synchronization of adhesion
at the leading edge and de-adhesion at the rear are
crucial to motility to occur. Interestingly, a compari-
son of the de-adhesion dynamics observed in our
studies with adhesion dynamics of endothelial cells32
reveals surprising similarities between the two pro-
cesses. Both processes are marked by an initial lag
followed by rapid change in cell–substrate contact area
and an eventual saturation. Similar adhesion dynamics
have also been observed in the spreading of mouse
embryonic ﬁbroblasts on ﬁbronectin-coated substrates,
and reveal phase transitions during cell spreading.7
However, the time scales of these two processes are
different, with de-adhesion occurring within seconds,
and adhesion occurring in tens of minutes. Also, while
the lag phase during spreading depends on ligand
density,8,32 the lag phase during de-adhesion is related
to trypsin diffusion times. However, the increase in
cell-exerted traction forces during spreading,9,32
and the delayed de-adhesion response of blebbistatin-
treated cells illustrate the role of myosin in modulating
both these processes.
In conclusion, we have developed a simple assay to
determine cell mechanical properties from de-adhesive
dynamics following trypsin-induced detachment and
shown that de-adhesion time constants correlate
inversely with cell contractility or stiﬀness. The sensi-
tivity of our assay allows us to detect diﬀerences in cell
mechanics associated with changes in cell stiﬀness of
less than 1 kPa and makes our assay a useful tool for
studying induced diﬀerences in mechanical properties
for a single cell type, as well as variations in cell
mechanics across multiple cell types. Furthermore, by
manipulating the trypsin concentration, our method
can be adapted to explore the interplay between
adhesion and contractility. We anticipate that the
simplicity of our technique will make it particularly
suitable for integration with high-throughput analyti-
cal techniques for use in diagnostic and bioprocessing
applications.
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